Literature DB >> 29563154

Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.

Edgard M Mejia1,2, Hana Zegallai1, Eric D Bouchard3, Versha Banerji3, Amir Ravandi4, Grant M Hatch5,2,6.   

Abstract

The mitochondrial polyglycerophospholipid cardiolipin (CL) is remodeled to obtain specific fatty acyl chains. This is predominantly accomplished by the transacylase enzyme tafazzin (TAZ). Barth syndrome (BTHS) patients with TAZ gene mutations exhibit impaired TAZ activity and loss in mitochondrial respiratory function. Previous studies identified monolysocardiolipin acyltransferase-1 (MLCL AT-1) as a mitochondrial enzyme capable of remodeling CL with fatty acid. In this study, we analyzed what relationship, if any, exists between TAZ and MLCL AT-1 with regard to CL remodeling and whether transfection of BTHS lymphoblasts with an MLCL AT-1 expression construct improves mitochondrial respiratory function. In healthy lymphoblasts, reduction in TAZ expression through TAZ RNAi transfection resulted in a compensatory increase in MLCL AT-1 mRNA, protein, and enzyme activity, but CL mass was unaltered. In contrast, BTHS lymphoblasts exhibited decreased TAZ gene and protein expression but in addition decreased MLCL AT-1 expression and CL mass. Transfection of BTHS lymphoblasts with MLCL AT-1 expression construct increased CL, improved mitochondrial basal respiration and protein leak, and decreased the proportion of cells producing superoxide but did not restore CL molecular species composition to control levels. In addition, BTHS lymphoblasts exhibited higher rates of glycolysis compared with healthy controls to compensate for reduced mitochondrial respiratory function. Mitochondrial supercomplex assembly was significantly impaired in BTHS lymphoblasts, and transfection of BTHS lymphoblasts with MLCL AT-1 expression construct did not restore supercomplex assembly. The results suggest that expression of MLCL AT-1 depends on functional TAZ in healthy cells. In addition, transfection of BTHS lymphoblasts with an MLCL AT-1 expression construct compensates, but not completely, for loss of mitochondrial respiratory function.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cardiolipin; genetic disease; lipid metabolism; mitochondrial disease; phospholipid metabolism

Mesh:

Substances:

Year:  2018        PMID: 29563154      PMCID: PMC5961033          DOI: 10.1074/jbc.RA117.001024

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane.

Authors:  Tomomi Kuwana; Mason R Mackey; Guy Perkins; Mark H Ellisman; Martin Latterich; Roger Schneiter; Douglas R Green; Donald D Newmeyer
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

2.  Acylation of monolysocardiolipin in rat heart.

Authors:  B J Ma; W A Taylor; V W Dolinsky; G M Hatch
Journal:  J Lipid Res       Date:  1999-10       Impact factor: 5.922

3.  Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis.

Authors:  Fredoen Valianpour; Voula Mitsakos; Dimitri Schlemmer; Jeffrey A Towbin; Juliet M Taylor; Paul G Ekert; David R Thorburn; Arnold Munnich; Ronald J A Wanders; Peter G Barth; Frédéric M Vaz
Journal:  J Lipid Res       Date:  2005-04-01       Impact factor: 5.922

4.  X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria.

Authors:  R I Kelley; J P Cheatham; B J Clark; M A Nigro; B R Powell; G W Sherwood; J T Sladky; W P Swisher
Journal:  J Pediatr       Date:  1991-11       Impact factor: 4.406

5.  Reactive oxygen species generated by the mitochondrial respiratory chain affect the complex III activity via cardiolipin peroxidation in beef-heart submitochondrial particles.

Authors:  G Paradies; G Petrosillo; M Pistolese; F M Ruggiero
Journal:  Mitochondrion       Date:  2001-08       Impact factor: 4.160

Review 6.  Cardiolipin metabolism and Barth Syndrome.

Authors:  Kristin D Hauff; Grant M Hatch
Journal:  Prog Lipid Res       Date:  2006-01-18       Impact factor: 16.195

7.  Regulation of cardiolipin biosynthesis in H9c2 cardiac myoblasts by cytidine 5'-triphosphate.

Authors:  G M Hatch; G McClarty
Journal:  J Biol Chem       Date:  1996-10-18       Impact factor: 5.157

8.  Mechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae Tafazzin.

Authors:  Masato Abe; Yui Hasegawa; Masahide Oku; Yoshiki Sawada; Eriko Tanaka; Yasuyoshi Sakai; Hideto Miyoshi
Journal:  J Biol Chem       Date:  2016-06-06       Impact factor: 5.157

9.  Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome.

Authors:  Michael Schlame; Jeffrey A Towbin; Paul M Heerdt; Roswitha Jehle; Salvatore DiMauro; Thomas J J Blanck
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

10.  Human trifunctional protein alpha links cardiolipin remodeling to beta-oxidation.

Authors:  William A Taylor; Edgard M Mejia; Ryan W Mitchell; Patrick C Choy; Genevieve C Sparagna; Grant M Hatch
Journal:  PLoS One       Date:  2012-11-09       Impact factor: 3.240

View more
  14 in total

Review 1.  Mitochondrial dysfunctions in barth syndrome.

Authors:  Sagnika Ghosh; Donna M Iadarola; Writoban Basu Ball; Vishal M Gohil
Journal:  IUBMB Life       Date:  2019-02-11       Impact factor: 3.885

Review 2.  Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.

Authors:  Hana M Zegallai; Grant M Hatch
Journal:  Mol Cell Biochem       Date:  2021-01-07       Impact factor: 3.396

Review 3.  TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome.

Authors:  Anders O Garlid; Calvin T Schaffer; Jaewoo Kim; Hirsh Bhatt; Vladimir Guevara-Gonzalez; Peipei Ping
Journal:  Gene       Date:  2019-10-21       Impact factor: 3.688

4.  Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.

Authors:  Laura K Cole; Jin Hee Kim; Andrew A Amoscato; Yulia Y Tyurina; Hülya Bay R; Benyamin Karimi; Tabrez J Siddiqui; Valerian E Kagan; Grant M Hatch; Tiina M Kauppinen
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-07-25       Impact factor: 5.187

5.  Current Knowledge on the Role of Cardiolipin Remodeling in the Context of Lipid Oxidation and Barth Syndrome.

Authors:  Zhuqing Liang; Michael W Schmidtke; Miriam L Greenberg
Journal:  Front Mol Biosci       Date:  2022-05-27

6.  Tafazzin Deficiency Reduces Basal Insulin Secretion and Mitochondrial Function in Pancreatic Islets From Male Mice.

Authors:  Laura K Cole; Prasoon Agarwal; Christine A Doucette; Mario Fonseca; Bo Xiang; Genevieve C Sparagna; Nivedita Seshadri; Marilyne Vandel; Vernon W Dolinsky; Grant M Hatch
Journal:  Endocrinology       Date:  2021-07-01       Impact factor: 4.736

7.  Role of Lysocardiolipin Acyltransferase in Cigarette Smoke-Induced Lung Epithelial Cell Mitochondrial ROS, Mitochondrial Dynamics, and Apoptosis.

Authors:  Mounica Bandela; Vidyani Suryadevara; Panfeng Fu; Sekhar P Reddy; Kamesh Bikkavilli; Long Shuang Huang; Sugasini Dhavamani; Papasani V Subbaiah; Sunit Singla; Steven M Dudek; Lorraine B Ware; Ramaswamy Ramchandran; Viswanathan Natarajan
Journal:  Cell Biochem Biophys       Date:  2021-11-01       Impact factor: 2.989

Review 8.  Metabolic Alterations Caused by Defective Cardiolipin Remodeling in Inherited Cardiomyopathies.

Authors:  Christina Wasmus; Jan Dudek
Journal:  Life (Basel)       Date:  2020-11-11

Review 9.  Studying Lipid-Related Pathophysiology Using the Yeast Model.

Authors:  Tyler Ralph-Epps; Chisom J Onu; Linh Vo; Michael W Schmidtke; Anh Le; Miriam L Greenberg
Journal:  Front Physiol       Date:  2021-10-28       Impact factor: 4.566

10.  Phosphokinome Analysis of Barth Syndrome Lymphoblasts Identify Novel Targets in the Pathophysiology of the Disease.

Authors:  Prasoon Agarwal; Laura K Cole; Abin Chandrakumar; Kristin D Hauff; Amir Ravandi; Vernon W Dolinsky; Grant M Hatch
Journal:  Int J Mol Sci       Date:  2018-07-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.